Sandip I. Patel - 09 Mar 2023 Form 4 Insider Report for Monterey Innovation Acquisition Corp

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Mar 2023, 20:44:11 UTC
Prior SEC filing
30 Sep 2021
Next SEC filing
16 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason T. Simon, as Attorney-in-Fact

Key filing fact

Sandip I. Patel filed Form 4 for Monterey Innovation Acquisition Corp on 13 Mar 2023.

Key facts

  • This page summarizes Sandip I. Patel's Form 4 filing for Monterey Innovation Acquisition Corp.
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Mar 2023, 20:44.

Change

  • Previous filing in this sequence was filed on 30 Sep 2021.
  • Current net transaction value: -$3,420.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MTRY transaction

Common Stock

Sale

Transaction value
$3,420
Shares
-570,000
Change %
-30%
Price
$0.006000*
Shares after
1,342,500
Date
09 Mar 2023
Ownership
See footnote
Footnotes
F1, F2
MTRY transaction

Common Stock

Other

Transaction value
Shares
+75,000
Change %
+5.6%
Price
Shares after
1,417,500
Date
09 Mar 2023
Ownership
See footnote
Footnotes
F1, F3
MTRY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
35,000
Date
09 Mar 2023
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The shares of common stock (the "founder shares") of Monterey Innovation Acquisition Corp. (the "Company") are held directly by NorthStar Bio Ventures, LLC (the "NorthStar Co-Sponsor"). The Reporting Person is a manager of NorthStar Co-Sponsor. Accordingly, the Reporting Person has voting and dispositive power over the founder shares held by NorthStar Co-Sponsor and may be deemed to beneficially own such shares. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Footnote F2

In connection with the Company's previously disclosed management transition, and pursuant to share transfer agreements dated March 9, 2023, NorthStar Co-Sponsor transferred (i) 478,125 founder shares to Chardan Monterey Investments LLC and (ii) 30,625 founder shares to each of the Company's three new directors, in each case, at a price of $0.006 per share.

Footnote F3

On March 9, 2023, Sanjeev Satyal resigned as the Company's Chief Executive Officer and, pursuant to an assignment dated March 9, 2023, transferred back to NorthStar Co-Sponsor 75,000 of the founder shares that he received from NorthStar Co-Sponsor prior to the Company's initial public offering.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .